Helicobacter pylori

Postgraduate Medical Journal

Volumn 76, Issue 893, 2000, Pages 141-144

  Bateson, Malcolm C ^a  

^a BISHOP AUCKLAND GENERAL HOSPITAL   (United Kingdom)

Author keywords

Helicobacter pylori

Indexed keywords

ACETYLSALICYLIC ACID; ACID; AMMONIA; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL DNA; BISMUTH; CARBON DIOXIDE; CLARITHROMYCIN; EOSIN; HEMATOXYLIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PENICILLIN G; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; STEROID; TETRACYCLINE; TINIDAZOLE; UNINDEXED DRUG; UREA; UREASE;

BREATH ANALYSIS; DUODENUM ULCER; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; STOMACH BIOPSY; STOMACH LYMPHOMA; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0034058973     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.893.141     Document Type: Review

References (49)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89:S116.
2. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
3. Goddard AF, Logan RPH. Review article: urea breath tests for detecting Helicobacter pylori. Aliment Pharmacol Ther 1997;11:641-9.
4. McColl KEL, El-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.
5. Penston JG, Mistry KR. Eradication of Helicobacter pylori in general practice. Aliment Pharmacol Ther 1996;10:139-45.
6. Huang JQ, Hunt RH. Are one-week anti-Helicobacter pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non-ulcer dyspepsia (NUD)? A meta-analysis. Digestion 1998;59:413.
7. Duggan A, Logan R, Knifton A, Logan R. Accuracy of near patient blood tests for Helicobacter pylori. Lancet 1996;348:617.
8. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Halell SL. A low rate of re-infection following effective therapy against H. pylori in a developing nation (China). Gastroenterology 1998;114: 256-61.
9. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:41-6.
10. van Zwet AA, Thijs JC, de Graaf B. Explanav tions for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995;39: 250-2.
11. Weel JF, van der Hulst RW, Gerrits Y, Tytgat GN, van der Ende A, Dankert J. Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease. J Clin Microbiol 1996;34:2158-62.
12. Walt RP. Metronidazole resistant H. pylori - of questionable clinical importance. Lancet 1996; 348:489-50.
13. Strom M, Sorberg M, Jonsson KA. Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori. Aliment Pharmacol Ther 1997;11;311-6.
14. Bateson MC, Winn G, Ahmad F. Sensitivity of Helicobacter pylori to metronidazole. Eur J Cancer Prevent 1997;6:300-2.
15. Breur T, Kim JG, Gurer IE, et al. Successful low dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1997;11:523-7.
16. Miyaji H, Azuma T, Ito S, et al. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther 1997;11:1131-6.
17. Pilotto A, Rassu M, Franceschi M, Furlan F, D'Allotta P, Scagnelli M, Valerio G. Susceptibility of Helicobacter pylori to different antibiotics and effects of the resistance on eradication rates. Ital J Gastroenterol Hepatol 1997;29:A60.
18. Moayyedi P, Ragunathan PL, Mapstone N, Axon AT, Tompkins DS. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1998;33: 160-3.
19. Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxycillin - influence on treatment outcome. Am J Gastroenterol 1998;93:386-9.
20. Bell GD, Powell K, Burridge SM, et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-35.
21. Morris AI. Duodenal ulcer and H pylori. Proc R Coll Physicians Edin 1994;24:37-41.
22. Bazzoli F, Gullini S, Zagari RM, et al. Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Hp. and the recurrence of duodenal ulcer. Gut 1995;37:A241.
23. Delchier JC, Elamine I, Goldfain D, Chaussade S, Barthelemy P, Idstrom JP. Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10: 263-8.
24. Holtmann G, Layer P, Goebell H. Proton pump inhibitors or H, receptor antagonists for Helicobacter pylori eradication - a meta-analysis. Lancet 1996;347:763.
25. Jaup BH, Norrby A. Comparison of two low dose one week triple therapy regimens with and without metronidazole for cure of H. pylori infection. Aliment Pharmacol Ther 1996;10:275-7.
26. Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Borsch G. One week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:207-10.
27. Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10:285-8.
28. Yousfi MM, El-Zimaity HMT, Genta RM, Graham DY. One week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996;10:617-21.
29. Harris AW and the Lansoprazole Helicobacter Study Group. Incidence of duodenal healing after one week of proton pump inhibitor therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998;12:741-5.
30. Goh KL, Parasakthi N, Chuah SY, Cheah PL, Loss YL, Chin SC. Comparison of two 1-week low dose omeprazole triple therapies - optimal treatment for Helicobacter pylori infection? Aliment Pharmacol Ther 1997;11:1115-8.
31. Misiewicz JJ. Harris AW, Bardhan KD, et al, and the Lansoprazole Helicobacter Study Group. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 1997;41: 735-9.
32. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD, and the RBC H pylori study group. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996;10:251-61.
33. Wyeth JW, Pounder RE, Duggan AE, et al. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:623-30.
34. Bardhan KD, Dallair C, Eisold H, Duggan AE. Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut 1997;41:181-6.
35. Delle Cave M, Beneduce F, Iovene MR, et al. One week therapy combining omeprazole or ranitidine bismuth citrate with two antibiotics for eradication of Helicobacter pylori infection: a preliminary study. Ital J Gastroenterol Hepatol 1997;29:A187.
36. Marchi S, Costa F, Belcari C, et al. Ranitidine bismuth citrate plus amoxycillin and clarithromycin therapy for one week is effective in eradicating Helicobacter pylori and healing duodenal ulcer. Ital J Gastroenterol Hepatol 1997;29:A127.
37. Peyre S, Rizzi R, Bertello PD. Short term course ranitidine bismuth citrate in association with antibiotics for Helicobacter pylori (Hp) eradication in duodenal ulcer (DU). Ital J Gastroenterol Hepatol 1997;29:A136.
38. Savarino V, Mansi C, Mele MR, et al. A new 1 week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. Aliment Pharmacol Ther 1997;11: 699-703.
39. Williams MP, Hamilton MR, Sercombe JC, Pounder RE. Seven day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Aliment Pharmacol Ther 1997;11:705-10.
40. Bateson MC, Diffey B. Improving management of duodenal ulcer disease. Postgrad Med J 1997; 73:717-9.
41. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
42. Hosking SW, Ling TKW, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ 1992;305:502-4.
43. de Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:633-8.
44. de Boer WA, van Etten RJ, Lai JY, Schneeberger PM, van de Wouw BA, Driessen WM. Effectiveness of quadruple therapy using lansoprazole instead of omeprazole in curing Helicobacter pylori infection. Helicobacter 1996;1:145-50.
45. Lai JYL, de Boer WA, Driessen WMM, Geuskens LM. Long term follow up after cure of Helicobacter pylori infection with 4 days of quadruple therapy. Aliment Pharmacol Ther 1996;10:645-50.
46. de Boer SY, Siem TH. Four day quadruple therapy as a routine treatment for Helicobacter pvlori infection. Aliment Pharmacol Ther 1997; 11:1119-21.
47. Graham DY, Hoffman J, El-Zimaity HMT, Graham DP, Osato M. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:935-8.
48. Tzivras M, Balatsos V, Souyioultzis S, Tsirantonaki M, Skandalis N, Archimandritis A. High eradication rate of Helicobacter pylori using a four drug regimen in patients previously treated unsuccessfully. Clin Therapeut 1997;19:906-12.
49. Treiber G, Ammon S, Schneider E, Klotz U. Amoxycillin/metronidazole/omeprazole/ clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. Helicobacter 1998;3:54-8.